Three Achievement Awards at ASH 2016

More than 27.000 physicians, scientists and clinician-scientists from all over the world participated in this year’s Annual Meeting of the American Society of Hematology (ASH) from December 3-6, 2016 in San Diego. This year, our group contributed to this conference with three presentations. Considering the outreach and the limited slots to present data, we are very proud that all three participating scientists from the Beilhack lab were also selected for the prestigious ASH Abstract Achievement Awards: Musga Qureischi, who joined the group for her PhD project in 2016; Dr. Antonio Solimando, a physician-scientist and visiting scholar from the University of Bari, Italy; and Natraj Kalleda, who recently completed his PhD thesis.

Three award selected presentations on diverse topics

In his lecture on Sunday morning Dr. Antonio Solimando reported new results on the interaction of multiple myeloma cells with the bone marrow microenvironment. Also on Sunday, Natraj Kalleda presented novel insights into adoptive cellular therapy for invasive aspergillus infections. In the session for allogeneic hematopoietic cell transplantation on Monday, Musga Qureischi gave a talk on our collaborative research project with PD Dr. Friederike Berberich-Siebelt on molecular signaling in alloreactive T cells in GVHD. The Annual ASH Conference is considered as the most important venue in the broad field of hematology including research for hematologic malignancies, hematopoietic stem cell transplantation and immunotherapy.